(Q46908025)

English

Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers

scientific article published in February 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

John S Markowitz

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

C Lindsay DeVane

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Robert J Malcolm

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Holly A Gefroh

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Jun-Sheng Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Hao-Jie Zhu

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Jennifer L Donovan

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

46

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

164-171

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Dopamine agonists in the treatment of Parkinson s disease past, present and future

1 reference

https://api.crossref.org/works/10.1177%2F0091270005283839

21 January 2018

Identifiers

10.1177/0091270005283839

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16432268

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46908025&oldid=2137479098"